Publication: The influence of digital PET/CT on diagnostic certainty and interrater reliability in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer.
cris.virtual.author-orcid | 0000-0002-1954-736X | |
cris.virtualsource.author-orcid | 3f7e3e49-9100-4a4f-8957-9f101279afe7 | |
cris.virtualsource.author-orcid | 8497fd72-07dc-4061-a2bf-5cd59487b2e3 | |
cris.virtualsource.author-orcid | 03a6cdf6-f76b-494b-b378-a7129f91b765 | |
cris.virtualsource.author-orcid | 8af5d20d-9d8f-47d5-be1a-9be3d54840eb | |
cris.virtualsource.author-orcid | c03fd116-7ba8-43e2-86ea-76609dcfd482 | |
cris.virtualsource.author-orcid | 16650768-b4af-44fc-a7e6-c0a796ba1199 | |
cris.virtualsource.author-orcid | bd991341-4294-4586-b80f-40b024a93af3 | |
cris.virtualsource.author-orcid | ad1a702a-efe4-4ef4-a1f4-f413bd080668 | |
datacite.rights | open.access | |
dc.contributor.author | Alberts, Ian Leigh | |
dc.contributor.author | Hünermund, Jan-Niklas | |
dc.contributor.author | Sachpekidis, Christos | |
dc.contributor.author | Mingels, Clemens | |
dc.contributor.author | Fech, Viktor | |
dc.contributor.author | Bohn, Karl Peter | |
dc.contributor.author | Rominger, Axel Oliver | |
dc.contributor.author | Afshar Oromieh, Ali | |
dc.date.accessioned | 2024-10-06T18:52:07Z | |
dc.date.available | 2024-10-06T18:52:07Z | |
dc.date.issued | 2021-10 | |
dc.description.abstract | OBJECTIVE To investigate the impact of digital PET/CT on diagnostic certainty, patient-based sensitivity and interrater reliability. METHODS Four physicians retrospectively evaluated two matched cohorts of patients undergoing [68Ga]Ga-PSMA-11 PET/CT on a digital (dPET/CT n = 65) or an analogue scanner (aPET/CT n = 65) for recurrent prostate cancer between 11/2018 and 03/2019. The number of equivocal and pathological lesions as well as the frequency of discrepant findings and the interrater reliability for the two scanners were compared. RESULTS dPET/CT detected more lesions than aPET/CT (p < 0.001). A higher number of pathological scans were observed for dPET/CT (83% vs. 57%, p < 0.001). The true-positive rate at follow-up was 100% for dPET/CT compared to 84% for aPET/CT (p < 0.001). The proportion of lesions rated as non-pathological as a total of all PSMA-avid lesions detected for dPET/CT was comparable to aPET/CT (61.8% vs. 57.0%, p = 0.99). Neither a higher rate of diagnostically uncertain lesions (11.5% dPET/CT vs. 13.7% aPET/CT, p = 0.95) nor discrepant scans (where one or more readers differed in opinion as to whether the scan is pathological) were observed (18% dPET/CT vs. 17% aPET/CT, p = 0.76). Interrater reliability for pathological lesions was excellent for both scanner types (Cronbach's α = 0.923 dPET/CT; α = 0.948 aPET/CT) and interrater agreement was substantial for dPET/CT (Krippendorf's α = 0.701) and almost perfect in aPET/CT (α = 0.802). CONCLUSIONS A higher detection rate for pathological lesions for dPET/CT compared with aPET/CT in multiple readers was observed. This improved sensitivity was coupled with an improved true-positive rate and was not associated with increased diagnostic uncertainty, rate of non-specific lesions, or reduced interrater reliability. KEY POINTS • New generation digital scanners detect more cancer lesions in men with prostate cancer. • When using digital scanners, the doctors are able to diagnose prostate cancer lesions with better certainty • When using digital scanners, the doctors do not disagree with each other more than with other scanner types. | |
dc.description.numberOfPages | 10 | |
dc.description.sponsorship | Universitätsklinik für Nuklearmedizin | |
dc.identifier.doi | 10.48350/161733 | |
dc.identifier.pmid | 33856522 | |
dc.identifier.publisherDOI | 10.1007/s00330-021-07870-5 | |
dc.identifier.uri | https://boris-portal.unibe.ch/handle/20.500.12422/57899 | |
dc.language.iso | en | |
dc.publisher | Springer | |
dc.relation.ispartof | European radiology | |
dc.relation.issn | 1432-1084 | |
dc.relation.organization | DCD5A442BAD5E17DE0405C82790C4DE2 | |
dc.subject | Molecular imaging Nuclear medicine Positron emission tomography Prostate cancer | |
dc.subject.ddc | 600 - Technology::610 - Medicine & health | |
dc.title | The influence of digital PET/CT on diagnostic certainty and interrater reliability in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer. | |
dc.type | article | |
dspace.entity.type | Publication | |
dspace.file.type | text | |
oaire.citation.endPage | 8039 | |
oaire.citation.issue | 10 | |
oaire.citation.startPage | 8030 | |
oaire.citation.volume | 31 | |
oairecerif.author.affiliation | Universitätsklinik für Nuklearmedizin | |
oairecerif.author.affiliation | Universitätsklinik für Nuklearmedizin | |
oairecerif.author.affiliation | Universitätsklinik für Nuklearmedizin | |
oairecerif.author.affiliation | Universitätsklinik für Nuklearmedizin | |
oairecerif.author.affiliation | Universitätsklinik für Nuklearmedizin | |
oairecerif.author.affiliation | Universitätsklinik für Nuklearmedizin | |
oairecerif.author.affiliation | Universitätsklinik für Nuklearmedizin | |
oairecerif.author.affiliation | Universitätsklinik für Nuklearmedizin | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.contributor.role | creator | |
unibe.date.licenseChanged | 2022-01-05 16:25:02 | |
unibe.description.ispublished | pub | |
unibe.eprints.legacyId | 161733 | |
unibe.refereed | true | |
unibe.subtype.article | journal |
Files
Original bundle
1 - 1 of 1
- Name:
- 259_2021_Article_5282.pdf
- Size:
- 4.06 MB
- Format:
- Adobe Portable Document Format
- File Type:
- text
- License:
- https://creativecommons.org/licenses/by/4.0
- Content:
- published